Literature DB >> 2304893

Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo.

J Grenhoff1, C S Tung, L Ugedo, T H Svensson.   

Abstract

The effect of the putative antipsychotic compound amperozide on the electrical activity of single identified midbrain dopamine (DA) neurons was investigated in the chloral hydrate anesthetized male rat. While the activity of DA cells in the substantia nigra was unaffected, DA neurons of the ventral tegmental area (VTA), the origin of the mesolimbocortical DA system, were affected in either of two ways: 1) increased firing rate and burst firing, i.e. an excitation, or 2) regularization of the firing pattern. Reversible cold inactivation of the medical prefrontal cortex (PFC) induced a pacemaker-like firing of VTA-DA cells, an effect blocked by amperozide in the cells excited by the drug. Cells responding with a regularization were not protected against the effect of PFC inactivation. These different effects of amperozide, which may in part be mediated by 5-HT2 receptor blockade, suggest an antipsychotic activity of amperozide, particularly in schizophrenia with negative symptoms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304893     DOI: 10.1111/j.1600-0773.1990.tb01603.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  5 in total

1.  Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.

Authors:  A Schotte; P F Janssen; W Gommeren; W H Luyten; P Van Gompel; A S Lesage; K De Loore; J E Leysen
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

2.  Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

Authors:  P Hertel; G G Nomikos; M Iurlo; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

3.  Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist.

Authors:  R Axelsson; A Nilsson; E Christensson; A Björk
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.

Authors:  J L Andersson; G G Nomikos; M Marcus; P Hertel; J M Mathé; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

5.  Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.

Authors:  G G Nomikos; M Iurlo; J L Andersson; K Kimura; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.